Skip to main content

Please select
your location below

Attenzione, le pagine di questa sezione sono disponibili solo in lingua inglese.

By selecting the International view, you verify that you reside outside of the USA and you wish to view DiaSorin Molecular’s International Product Information. This material is intended for International (non-USA) site visitors only.

Pursuant to the Guidelines of the Ministry of Health dated 28/03/2013 related to health advertising concerning medical devices, in vitro diagnostic medical devices and medical-surgical devices, we hereby inform you that the information contained in this website and to which you are going to access is exclusively intended for professionaloperators.

ご注意

現在、日本語に対応しているのは、Luminex LTGのセクションとLuminex LTGのサービス&サポートページのみです。

Currently, only the Luminex LTG section and the Service & Support pages regarding Luminex LTG are available in Japanese.

Direct links

LIAISON® BRAHMS MR-proADMTM

A powerful solution for Emergency Department (ED) decision-making.

Accurate prioritization of critically ill patients with suspected infection for timely and informed decision-making when every second counts.

Tell us who you are

Indications for use

Diagnosis

Evaluate risk assessment and prognosis in suspected acute viral, bacterial, parasitic or fungal infections

Target patient

Adults

Use area

Emergency department, urgent care and hospitalized patients

Background

Empower your lab with a new solution to support ED and ICU physicians in improving patient care

The role of the clinical laboratory in supporting clinical decision-making is crucial. Empower your laboratory with the new MR-proADMTM biomarker, to assess disease severity and potential disease progression in patients presenting to the emergency department (ED) with a suspected acute infection.

LIAISON® BRAHMS MR-proADMTM  is a high-quality quantitative CLIA assay that measures the concentration of the blood biomarker Mid-regional pro-adrenomedullin (MR-proADMTM) to assess disease severity and prognosis in patients with a suspected infection.  

Incorporation into the laboratory routine may therefore aid rapid clinical decision-making to either initiate, escalate or intensify early treatment strategies, or identify patients suitable for safe out-patient treatment.   

How it works

LIAISON® BRAHMS MR-proADMTM automatically quantifies the circulating MR-proADMTM in a plasma sample, to evaluate the severity of endothelial dysfunction and the risk of organ failure and/or sepsis development in several clinical conditions: sepsis and septic shock, urinary tract infections (UTI); lower respiratory tract infections (LRTI) and kidney diseases.  

Accurately detects patients at risk in the ED and ICU

01

No need for specialized staff

The fully automated LIAISON® BRAHMS MR-proADMTM test is part of Diasorin’s comprehensive portfolio of immunoassays, allowing any laboratory to optimize its diagnostic pathway while meeting critical emergency department timelines.

02

35 minutes to results

Fast results give clinicians swift answers in emergency situations.

03

High-quality, ready-to-use CLIA assay

Standardized and unbiased results with automatic processing ensures optimal harmonization between urgent, specialty and routine tests

proADM

Why use LIAISON® BRAHMS MR-proADMTM

Quick, objective diagnostics to improve your precision and responsiveness.

Pioneering, easy-to-use diagnostic solution

The easy, intuitive process ensures perfect harmonization between urgent, specialty and routine tests.

Meet critical emergency department timelines

Optimize your diagnostic pathway and deliver faster time-to-results without the need for additional staff.

Better performance for an innovative biomarker

MR-proADMTM offers an accurate and reliable evaluation of endothelial and microcirculatory damage to rapidly identify the risk of organ damage.

Empower your lab

Dynamic throughput with fully automated processing improves response time without increasing operational costs.

To be used on

Designed for both specialty and routine tests, LIAISON® XL and LIAISON® XS immunoassay analyzers help your laboratory handle multiple patients and tests simultaneously. LIAISON® systems are trustworthy, intuitive and deliver automated continuous operation with minimal user intervention. The result is reduced turnaround time, optimal cost management and unmatched growth potential.

Fully Automated LIAISON® XL System - Diasorin

LIAISON® XL

Designed for large laboratories. Fuse the benefits of high throughput and high sensitivity within a powerful and fully automated system that can seamlessly connect to facilitate Total Laboratory Automation. 

詳しく調べる
Fully Automated LIAISON® XS System - Diasorin

LIAISON® XS

A fully automated, easy-to-use benchtop analyzer. Maximize productivity with optimal cost management, no daily maintenance, straightforward integration, and the same capabilities as Diasorin’s high-throughput analyzers. 

詳しく調べる

More details about our diagnostic solutions

Login to Dialog for additional resources

Login to our repository for instructions for use and user manuals, assay information, protocols and much more.

Dialog

Get in touch

If you need any information about our products, contact our specialists. 

Contact us

Need any help?

Get help with Diasorin products and services.

Ask for support

All the products in this family

Discover the range of specialty tests available

Discover more

Indications for use

Diagnosis

Evaluate risk assessment and prognosis in suspected acute viral, bacterial, parasitic or fungal infections

Target patient

Adults

Use area

Emergency department, urgent care and hospitalized patients

Background

Safely identify severely ill patients to improve ED risk stratification and triage level determination

There is a lack of validated tools (blood biomarkers and clinical scores) to timely assess potential disease progression and hospitalization decisions in patients presenting to the emergency department (ED) with a suspected acute infection.

LIAISON® BRAHMS MR-proADM™ is a high-quality quantitative CLIA assay that measures the concentration of the blood biomarker Mid-regional pro-adrenomedullin (MR-proADM™) to assess disease severity and prognosis in patients with a suspected infection.   

Incorporation into an early sepsis management protocol at ED triage, may therefore aid the rapid decision-making to either initiate, escalate or intensify early treatment strategies, or identify patients suitable for safe out-patient treatment.

How it works

LIAISON® BRAHMS MR-proADM™ automatically quantifies the circulating MR-proADM™ in a plasma sample, to evaluate the severity of endothelial dysfunction and the risk of organ failure and/or sepsis development in several clinical conditions: sepsis and septic shock, urinary tract infections (UTI); lower respiratory tract infections (LRTI) and kidney diseases. 

Accurately detects patients at risk in the ED and ICU

01

35 minutes to results

Aid timely clinical decision making (rule in/rule out hospitalization) using LIAISON® analyzers.

02

Optimized patient disposition at ED

Identify early signs of sepsis and organ failure in patients with an infection – regardless of its etiology: bacterial, viral or fungal.

03

Easy-to-interpret results

Explicit cut-off values indicate whether to hospitalize or safely discharge the patient.

proADM

Why use LIAISON® BRAHMS MR-proADMTM

Streamlines the clinical pathway.

Early diagnosis of sepsis

Early identification of high-risk patients, reduction of adverse events, improved prognosis at ED.

Improved bed management at ED

Better ED patient flow and more time and space for trauma and patients in need of ED resources.

Cost savings

Better overall utilization of hospital resources (e.g., less labor, fewer admissions and additional tests required).

Increased patient satisfaction

Optimized diagnostic pathway improves the quality of healthcare.

To be used on

Designed for both specialty and routine tests, LIAISON® XL and LIAISON® XS immunoassay analyzers help your laboratory handle multiple patients and tests simultaneously. LIAISON® systems are trustworthy, intuitive and deliver automated continuous operation with minimal user intervention. The result is reduced turnaround time, optimal cost management and unmatched growth potential.

Fully Automated LIAISON® XL System - Diasorin

LIAISON® XL

Designed for large laboratories. Fuse the benefits of high throughput and high sensitivity within a powerful and fully automated system that can seamlessly connect to facilitate Total Laboratory Automation. 

詳しく調べる
Fully Automated LIAISON® XS System - Diasorin

LIAISON® XS

A fully automated, easy-to-use benchtop analyzer. Maximize productivity with optimal cost management, no daily maintenance, straightforward integration, and the same capabilities as Diasorin’s high-throughput analyzers. 

詳しく調べる

More details about our diagnostic solutions

Login to Dialog for additional resources

Login to our repository for instructions for use and user manuals, assay information, protocols and much more.

Dialog

Get in touch

If you need any information about our products, contact our specialists. 

Contact us

Need any help?

Get help with Diasorin products and services.

Ask for support

All the products in this family

Discover the range of specialty tests available

Discover more